The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma
Authors:
- R. LouisRLR. Louis
- W. LenzWLW. Lenz
- R. HeyrmanRHR. Heyrman
- R. PauwelsRPR. Pauwels
- G. JoosGJG. Joos
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 19 (6) , 413-418
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- NK1 Receptor Stimulation Causes Contraction and Inositol Phosphate Increase in Medium-size Human Isolated BronchiAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Role of tachykinins in asthmaAllergy, 2000
- Role of tachykinins as contractile agonists of human airways in asthmaClinical & Experimental Allergy, 1999
- Involvement of Tachykinin NK3 Receptors in Citric Acid–induced Cough and Bronchial Responses in Guinea PigsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and coughEuropean Respiratory Journal, 1997
- Neutral Endopeptidase Activity and Airway Hyperresponsiveness to Neurokinin A in Asthmatic Subjects In VivoAmerican Review of Respiratory Disease, 1993
- Tachykinin receptors and tachykinin receptor antagonistsJournal of Autonomic Pharmacology, 1993
- Effects on the Isolated Human Bronchus of SR 48968, a Potent and Selective Nonpeptide Antagonist of the Neurokinin A (NK2) ReceptorsAmerican Review of Respiratory Disease, 1992
- The Effect of an Inhaled Neutral Endopeptidase Inhibitor, Thiorphan, on Airway Responses to Neurokinin A in Normal Humans In VivoAmerican Review of Respiratory Disease, 1992
- Characterization of Neurokinin Effects and Receptor Selectivity in Human Isolated BronchiAmerican Review of Respiratory Disease, 1989